89 related articles for article (PubMed ID: 15566283)
1. Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agents.
Elworthy TR; Brill ER; Chiou SS; Chu F; Harris JR; Hendricks RT; Huang J; Kim W; Lach LK; Mirzadegan T; Yee C; Walker KA
J Med Chem; 2004 Dec; 47(25):6124-7. PubMed ID: 15566283
[TBL] [Abstract][Full Text] [Related]
2. Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.
Elworthy TR; Kertesz DJ; Kim W; Roepel MG; Quattrocchio-Setti L; Smith DB; Tracy JL; Chow A; Li F; Brill ER; Lach LK; McGee D; Yang DS; Chiou SS
Bioorg Med Chem Lett; 2004 Apr; 14(7):1655-9. PubMed ID: 15026044
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
Xiao Y; Araldi GL; Zhao Z; Reddy A; Karra S; Brugger N; Fischer D; Palmer E; Bao B; McKenna SD
Bioorg Med Chem Lett; 2008 Jan; 18(2):821-4. PubMed ID: 18039575
[TBL] [Abstract][Full Text] [Related]
4. Lactams as prostanoid receptor ligands. Part 4: 2-Piperidones as selective EP4 receptor agonists.
Elworthy TR; Brill ER; Caires CC; Kim W; Lach LK; Tracy JL; Chiou SS
Bioorg Med Chem Lett; 2005 May; 15(10):2523-6. PubMed ID: 15863309
[TBL] [Abstract][Full Text] [Related]
5. The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.
Blouin M; Han Y; Burch J; Farand J; Mellon C; Gaudreault M; Wrona M; Lévesque JF; Denis D; Mathieu MC; Stocco R; Vigneault E; Therien A; Clark P; Rowland S; Xu D; O'Neill G; Ducharme Y; Friesen R
J Med Chem; 2010 Mar; 53(5):2227-38. PubMed ID: 20163116
[TBL] [Abstract][Full Text] [Related]
6. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
[TBL] [Abstract][Full Text] [Related]
9. Effects on improvement of blood flow in the chronically compressed cauda equina: comparison between a selective prostaglandin E receptor (EP4) agonist and a prostaglandin E1 derivate.
Sekiguchi M; Konno S; Kikuchi S
Spine (Phila Pa 1976); 2006 Apr; 31(8):869-72. PubMed ID: 16622373
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats.
Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K
Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain.
Colucci J; Boyd M; Berthelette C; Chiasson JF; Wang Z; Ducharme Y; Friesen R; Wrona M; Levesque JF; Denis D; Mathieu MC; Stocco R; Therien AG; Clarke P; Rowland S; Xu D; Han Y
Bioorg Med Chem Lett; 2010 Jun; 20(12):3760-3. PubMed ID: 20471829
[TBL] [Abstract][Full Text] [Related]
12. Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats.
Cameron KO; Lefker BA; Chu-Moyer MY; Crawford DT; Jardine PD; DeNinno SL; Gilbert S; Grasser WA; Ke H; Lu B; Owen TA; Paralkar VM; Qi H; Scott DO; Thompson DD; Tjoa CM; Zawistoski MP
Bioorg Med Chem Lett; 2006 Apr; 16(7):1799-802. PubMed ID: 16442794
[TBL] [Abstract][Full Text] [Related]
13. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
14. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
[TBL] [Abstract][Full Text] [Related]
15. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
Cameron KO; Lefker BA; Ke HZ; Li M; Zawistoski MP; Tjoa CM; Wright AS; DeNinno SL; Paralkar VM; Owen TA; Yu L; Thompson DD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2075-8. PubMed ID: 19250823
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
17. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
18. N-Aryl-gamma-lactams as integrin alphavbeta3 antagonists.
Xi N; Arvedson S; Eisenberg S; Han N; Handley M; Huang L; Huang Q; Kiselyov A; Liu Q; Lu Y; Nunez G; Osslund T; Powers D; Tasker AS; Wang L; Xiang T; Xu S; Zhang J; Zhu J; Kendall R; Dominguez C
Bioorg Med Chem Lett; 2004 Jun; 14(11):2905-9. PubMed ID: 15125957
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
